Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Mirna Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Enquire | Email | Print

ISBN: GDPH138284D
Published Date: Jan, 2014
Format: PDF
No of Pages: 18
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

Summary

Mirna Therapeutics, Inc. (Mirna) is a biopharmaceutical research service provider. The company researches and develops miRNA-directed oncology therapies. It has therapeutic use in hematologic cancers and provide opportunities for partnering and licensing. The company offers MRX34, a series of clinical therapeutic candidates to mimic the activity of a human miRNA. Mirna’s products include miR-34, miR-Rx02, miR-Rx06, miR-Rx01, miR-Rx07, miR16 and miR-Rx03. Its product candidates target cancers, such as solid and blood-borne tumors with a focus on hepatocellular carcinoma, non-small cell lung cancer, colorectal cancer, and pancreatic carcinoma. The company is a subsidiary of Asuragen, Inc. Mirna is headquartered in Austin, Texas, the US.

Mirna Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2
List of Tables 2
List of Figures 3
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 8
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Mirna Therapeutics Raises US$34 Million In Series C Financing 9
Mirna Therapeutics Secures US$1.5 Million In Venture Financing 11
Partnerships 12
RXi Pharma Enters Into Research Agreement With Mirna Therapeutics 12
Licensing Agreements 13
Marina Biotech Amends Licensing Agreement With Mirna Therapeutics For MicroRNA Therapeutics 13
Marina Biotech Enters Into Licensing Agreement With Mirna Therapeutics For MicroRNA Therapeutics 14
Mirna Therapeutics, Inc. - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables

Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 5
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
Mirna Therapeutics, Inc., Deals By Therapy Area, 2008 to YTD 2014 7
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 8
Mirna Therapeutics Raises US$34 Million In Series C Financing 9
Mirna Therapeutics Secures US$1.5 Million In Venture Financing 11
RXi Pharma Enters Into Research Agreement With Mirna Therapeutics 12
Marina Biotech Amends Licensing Agreement With Mirna Therapeutics For MicroRNA Therapeutics 13
Marina Biotech Enters Into Licensing Agreement With Mirna Therapeutics For MicroRNA Therapeutics 14
Mirna Therapeutics, Inc., Key Competitors 15
Mirna Therapeutics, Inc., Key Employees 16

List of Figures

Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 4
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 5
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 6
Mirna Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 7

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 378925, price: INR 15226, GlobalData

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online